Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jan;25(1):13-25.
doi: 10.1002/jmri.20767.

3D contrast-enhanced MR angiography

Affiliations
Review

3D contrast-enhanced MR angiography

Honglei Zhang et al. J Magn Reson Imaging. 2007 Jan.

Abstract

Safe, fast, accurate contrast arteriography can be obtained utilizing gadolinium (Gd) and 3D MR data acquisition for diagnosing vascular diseases. Optimizing contrast enhanced MRA (CE MRA), however, requires understanding the complex interplay between Gd injection timing, the Fourier mapping of 3D MR data acquisition and a multitude of parameters determining resolution, anatomic coverage, and sensitivity to motion artifacts. It is critical to time the bolus peak to coincide with central k-space data acquisition, which dominates image contrast. Oversampling the center of k-space allows reconstruction of multiple 3D acquisitions in rapid succession to time-resolve the passage of the contrast bolus. Parallel imaging increases resolution, shortens scan time and compresses the center of k-space into a shorter period of time, thereby minimizing motion and timing artifacts. Absence of ionizing radiation allows MRA to be repeated and combined with additional sequences to more fully characterize anatomy, flow, and physiology. Utilizing stepping table technology and thigh compression, whole body MRA is possible with a single contrast injection. As MR technology continues to advance, CE MRA becomes better and simpler to perform, increasing its efficacy in the diagnosis and management of vascular diseases.

PubMed Disclaimer

Comment in

  • Safety risks with gadolinium-based contrast agents.
    Marzella L, Blank M, Gelperin K, Johann-Liang R. Marzella L, et al. J Magn Reson Imaging. 2007 Sep;26(3):816; author reply 817. doi: 10.1002/jmri.21021. J Magn Reson Imaging. 2007. PMID: 17685423 No abstract available.

Similar articles

Cited by

MeSH terms